Deoxyadenosine blockade of G0 to G1 transition in lymphocytes: Possible involvement of protein kinases

Journal of Cellular Physiology

Volumn 166, Issue 2, 1996, Pages 288-295

  Sato, Toshiaki ^a,b   Chan, Teh Sheng ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b TOHOKU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CONCANAVALIN A; DEOXYADENOSINE; PENTOSTATIN; PROTEIN KINASE; STAUROSPORINE; ALKALOID; CALCIUM; DEOXYADENOSINE DERIVATIVE; DEOXYCYTIDINE; THYMIDINE;

ANIMAL CELL; ARTICLE; CALCIUM MOBILIZATION; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; COMBINED IMMUNODEFICIENCY; CYTOFLUOROMETRY; ENZYME DEFICIENCY; FLOW CYTOMETRY; IMMUNOBLOTTING; LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; ANIMAL; CELL CULTURE; CELL DEATH; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; LYMPHOCYTE ACTIVATION; METABOLISM; MOUSE STRAIN; PHYSIOLOGY; SPLEEN; WESTERN BLOTTING;

ANIMALIA;

ALKALOIDS; ANIMALS; BLOTTING, WESTERN; CALCIUM; CELL DEATH; CELLS, CULTURED; CONCANAVALIN A; DEOXYADENOSINES; DEOXYCYTIDINE; DRUG SYNERGISM; FLOW CYTOMETRY; G0 PHASE; G1 PHASE; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MICE; MICE, INBRED STRAINS; PROTEIN KINASES; SPLEEN; STAUROSPORINE; THYMIDINE;

EID: 0029671254     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4652(199602)166:2<288::AID-JCP6>3.0.CO;2-L     Document Type: Article

References (29)

1. Berridge, M.J. (1993) Inositol triphosphate and calcium signaling Nature 361:315-325.
2. Brox, L., Ng, A., Pollock, E., and Belch, A. (1984) DNA strand breaks induced in human T-lymphocytes by the combination of deoxyadenosine and deoxycoformycin. Cancer Res., 44:934-937.
3. Buc, H.A., Hamet, M., Moncion, A., and Perignon, J.L. (1991) Effect of chloroadenosine on phosphoinositide turnover in human T lymphoblasts activated through the TcR/CD3 complex. In: Purine and Pyrimidine Metabolism in Man. R.A. Harkness, ed. Plenum Press, New York, Vol. 7, pp. 101-104.
4. Carson, D.A., Kaye, J., and Wasson, D.B. (1980) Differences in deoxyadenosine metabolism in human and mouse lymphocytes. J. Immunol. 124:8-12.
5. Chan, T. (1977) The role of adenosine deaminase deficiency in the pathogenesis of a severe combined immunodeficiency disease. In: Fifth International Conference on Birth Defects. J.W. Littlefield, ed. Exeerpta Medica, Amsterdam, pp. 83-84.
6. Cohen, A., Hirschhorn, R., Horowitz, S.D., Rubinstein, Polmar, S.H., Hong, R., and Martin, D.W. (1978) Deoxyadenosine triphosphate as a potentially toxic metabolite in adenosine deaminase deficiency. Proc. Natl. Acad. Sci. U.S.A., 75:472-476.
7. Cohen, A., Barankiewicz, J., and Gelfand, E.W. (1985) Roles of alternative synthetic and eatabolic purine pathways in T lymphocyte differentiation. Ann. N.Y. Acad. Sci., 451:26-33.
8. Coleman, M.S., Donofrio, J., Hutton, J.J., Hahn, L., Daoud, A., Lampkin, B., and Dyminski, J. (1978) Identification and quantitation of adenine deoxynucleosides in erythrocytes of a patient with adenosine deaminase deficiency and severe combined immunodeficiency. J. Biol. Chem., 253:1619-1626.
9. Giblett, E.R., Anderson, J.E., Cohen, F., Pollare, B., and Meuwissen, H.J. (1972) Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity. Lancet ii:1067-1069.
10. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem., 260:3440-3450.
11. Herbert, J.M., Augereau, J.M., Gleye, J., and Maffrand, J.P. (1990) Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem. Biophys. Res. Commun., 172:993-999.
12. Hershfield, M.S., Fetter, J.E., Small, W.C., Bagnara, A.S., Williams, S.R., Ullman, B., Martin, D.W., Jr., Wasson, D.E., and Carson, D.A. (1981) Effects of mutational loss of adenosine kinase and deoxycytidine kinase on deoxyATP accumulation and deoxyadenosine toxicity in cultured CEM human T-lymphoblastoid cells. J. Biol. Chem. 257:6380-6386.
13. Hirschhorn, R. (1985) Complete and partial adenosine deaminase deficiency. Relationship of immune function to metabolite concentrations, enzyme activity, and effects of therapy. G. L. Tritsch, ed. Ann. N.Y. Acad. Sci., Vol. 451, pp. 20-25.
14. Hirschhorn, R., Nicknam, M.N., Eng, F., Yang, R., and Borkowsky, W. (1992) Novel deletion and a new missense mutation (Glu 217 Lys) at the catalytic site in two adenosine deaminase alleles of a patient with neonatal onset adenosine deaminase-severe combined immunodeficiency (ADA-SCID). J. Immunol., 149:3107-3112.
15. Kameoka, J., Tanaka, T., Nojima, Y., Schlossman, S.F., and Morimoto, C. (1993) Direct association of adenosine deaminase with a T cell activation antigen, CD26. Science, 261:466-469
16. Matsumoto, S.S., Yu, J., and Yu, A.L. (1983) Inhibition of RNA synthesis by deoxyadenosine plus deoxycoformycin in resting lymphocytes. J. Immunol., 131:2762-2766.
17. Meuth, M., and Green, H. (1974) Alterations leading to increased ribonucleotide reductase in cells selected for resistance to deoxynucleosides. Cell, 3:367-374.
18. Redelman, D., Bluestein, H.G., Cohen, A., Depper, J.M., and Wormsley, S. (1984) Deoxyadenosine (AdR) inhibition of newly activated lymphocytes: Blockade at the G0-G1 interface. J. Immunol., 132:2030-2038.
19. Rubinstein, A., Hirschhorn, R., Sicklick, M., and Murphy, R.A. (1979) In vivo and in vitro effects of thymosin and adenosine deaminase on adenosine-deaminase-deficient lymphocytes. N. Engl. J. Med., 300:387-392.
20. Ruers, T.J., Buurman, W.A., and van der Linden, C.J. (1987) 2′Deoxycoformycin and deoxyadenosine affect IL 2 production and IL 2 receptor expression on human T cells. J. Immunol., 138:116-122.
21. Scharenberg, J.G.M., Rijkers, G.T., Akkerman, J.W., Staal, G.E.J., and Zegers, B.J.M. (1990) Interference of deoxyadenosine with transmembrane signaling events in human T lymphocytes. Int. J. Immunopharmacol., 12:113-120.
22. Seto, S., Carrera, C.J., Kubota, M., Wasson, D.B., and Carson, D.A. (1985) Mechanism of deoxyadenosine and 2-chlorodeoxyadenosine toxicity to nondividing human lymphocytes. J. Clin. Invest., 75:377-383.
23. Seto, S., Carrera, C.J., Wasson, D.B., and Carson, D.A. (1986) Inhibition of DNA repair by deoxyadenosine in resting human lymphocytes. J. Immunol., 136:2839-2843.
24. Siaw, M.F., Mitchell, B.S., Koller, C.A., Coleman, M.S., and Hutton, J.J. (1980) ATP depletion as a consequence of adenosine deaminase inhibition in man. Proc. Natl. Acad. Sci. U.S.A., 77:6157-6161.
25. Simmonds, H.A., Levinsky, R.J., Perrett, D., and Webster, D.R. (1982) Reciprocal relationship between erythrocyte ATP and deoxy-ATP levels in inherited ADA deficiency. Biochem. Pharmacol., 31:947-951.
26. Thuillier, L., Garreau, F., and Cartier, P.H. (1981) Consequences of adenosine deaminase deficiency on thymocyte metabolism. Eur. J. Immunol., 11:788-794.
27. Traganos, F., Darzynkiewicz, Z., Sharpless, T., and Melamed, M.R. (1977) Simultaneous staining of ribonucleic and deoxyribonucleic acid in unfixed cells using acridine orange in a flow cytometric system. J. Histochem. Cytochem., 25:46-56.
28. Uberti, J., Lightbody, J., and Johnson, R.M. (1979) The effect of nucleosides and deoxycoformycin on adenosine and deoxyadenosine inhibition of human lymphocyte activation. J. Immunol., 123:189-193.
29. Ullman, B., Gudas, L.J., Cohen, A., and Martin, D.W. Jr. (1978) Deoxyadenosine metabolism and cytotoxicity in cultured mouse T lymphoma cells: A model for immunodeficiency disease. Cell, 14:365-375.